539 / 1481
Feng et al.
IJROBP
2007;28:2732-8.
Feng et al.
J Clin Oncol
2010;28:2732-8.
Target volume reduction (1)
•
Median follow-up 36 months.
•
Locoregional disease-free survival 96% at 3 years.
|
|
539 / 1481
Feng et al.
IJROBP
2007;28:2732-8.
Feng et al.
J Clin Oncol
2010;28:2732-8.
Target volume reduction (1)
•
Median follow-up 36 months.
•
Locoregional disease-free survival 96% at 3 years.